Answers are grounded in this paper and cite their sources.
We propose these three genes (FGF2, GAS1, and SFRP1) as potential biomarkers of ductal carcinoma in situ progression, suggesting that their downregulation may be involved in the transition of stationary to migrating invasive epithelial cells.
No takes yet. Share an insight, caveat, or question.
Dettogni et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: